FIRST AMENDMENT TO CLINICAL AND COMMERCIAL SUPPLY AGREEMENTClinical and Commercial Supply Agreement • August 7th, 2020 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 7th, 2020 Company IndustryThis FIRST AMENDMENT TO CLINICAL AND COMMERCIAL SUPPLY AGREEMENT is entered into as of June 12, 2020 (this “First Amendment”), by and between Aclaris Therapeutics, Inc., a Delaware corporation (“Aclaris”), and PeroxyChem LLC, a Delaware limited liability company (“PeroxyChem”). Aclaris and PeroxyChem are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”